RenovoDerm is a medical device company dedicated to revolutionizing wound healing. Their advanced line of wound care products aims to enhance tissue regeneration and expedite wound healing, all while mitigating the high costs and discomfort associated with existing solutions. The company's resorbable synthetic scaffolds facilitate tissue growth and regeneration, accelerating the body’s healing response. RenovoDerm's technology, developed by Jed Johnson, PhD., has demonstrated success in promoting tissue and hair follicle growth, as well as reducing scar tissue, particularly in the veterinary market. Founded in 2016 and headquartered in the United States, they recently secured a $250.00K Debt Financing investment on 17 May 2024. With a focus on Health Care and Medical Devices, RenovoDerm presents an innovative approach to wound care. For more information, visit their website at https:\/\/www.renovoderm.tech or reach out via email at [email protected]. Thank you.
General Information
Get notified when RenovoDerm moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track RenovoDerm
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About RenovoDerm
Taxonomy: Wound care, Medical device, Health, Regenerative, Tissue regeneration, MedTech
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | •••••• | - | 17 May 2024 | |
| Funding Round | •••••• | - | 08 Feb 2023 | |
| Seed Round | •••••• | 3 |
|
30 May 2017 |
RenovoDerm Alternatives & Competitors
An Australian biopharmaceutical company developing advanced wound healing products for medical and c...
FAQ About RenovoDerm
Don't just browse. Track.
Signal Tracker monitors RenovoDerm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.